Academic literature on the topic 'Resectable PHC'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Resectable PHC.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Resectable PHC"

1

Petreska, Anastazija, and Kiril Draganov. "Borderline resectable pancreatic ductal adenocarcinoma – "ABC" estimation criteria." Surgery 86, no. 1 (2022): 17–21. https://doi.org/10.5281/zenodo.15277955.

Full text
Abstract:
Preoperative judgement of pancreatic head cancer (PHC) resectability is still a problematic issue. More and more informative diagnostic methods are routinely used in everyday practice but none of them offers near to 100% sensitivity and specificity. It’s much easier toprove unresectability than resectability. The definition of “Borderline resectable PHC” is also a surgical challenge. The review of literature offered treats some of these problems from different points of view and gives current highlights and decision-making criteria. The final judgment of resectability is howe
APA, Harvard, Vancouver, ISO, and other styles
2

Enomoto, Laura M., Matthew E. B. Dixon, Allene Burdette, and Niraj J. Gusani. "Biliary Drainage Before and After Liver Resection for Perihilar Cholangiocarcinoma." American Surgeon 86, no. 6 (2020): 628–34. http://dx.doi.org/10.1177/0003134820923287.

Full text
Abstract:
Perihilar cholangiocarcinoma (PHC) is a rare tumor that requires surgical resection for a potential cure. The role of preoperative biliary drainage has long been debated, given its treatment of biliary sepsis and decompression of the future liver remnant (FLR), but high procedure-specific morbidity. The indications, methods, and outcomes for preoperative biliary drainage are discussed to serve as a guide for perioperative management of patients with resectable PHC. Multiple studies from the literature related to perihilar cholangiocarcinoma, biliary drainage, and management of the FLR were rev
APA, Harvard, Vancouver, ISO, and other styles
3

Sung, Min Kyu, Yejong Park, Bong Jun Kwak, et al. "Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location." Biomedicines 9, no. 11 (2021): 1706. http://dx.doi.org/10.3390/biomedicines9111706.

Full text
Abstract:
The impact of tumor location on patient survival in pancreatic ductal adenocarcinoma (PDAC) remains controversial. This study investigated the association between primary tumor location and survival rates for resectable PDAC. Additionally, we assessed if this association remains consistent across categories of the Tumor-Node-Metastasis staging system. We analyzed 2471 patients who underwent surgical resection between 2000 and 2018 at a single center. Subgroup analysis was performed according to the Tumor-Node-Metastasis staging system. Among the group, 67.9% (1677 patients) had pancreatic head
APA, Harvard, Vancouver, ISO, and other styles
4

Onoe, Shunsuke, Atsuyuki Maeda, Yuichi Takayama, et al. "The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma." Medical Principles and Practice 28, no. 6 (2019): 517–25. http://dx.doi.org/10.1159/000501017.

Full text
Abstract:
Objective: Although the prognostic significance of systematic inflammation-based scores, such as the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), and the prognostic nutritional index (PNI), has been explored in pancreatic cancers, few reports have investigated the lymphocyte-to-monocyte ratio (LMR). We aimed to retrospectively investigate the prognostic value of the preoperative LMR in patients with resectable pancreatic head cancer (PHC). Methods: From 2005 to 2016, 165 patients underwent pancreatoduodenectomy for PHC. All samples of peripheral blood were coll
APA, Harvard, Vancouver, ISO, and other styles
5

Mikhailov, I. V., V. M. Bondarenko, V. A. Kudryashov, et al. "One-Step Surgery in Pancreatic Head Cancer Complicated by Obstructive Jaundice." Health and Ecology Issues, no. 3 (September 28, 2019): 33–38. http://dx.doi.org/10.51523/2708-6011.2019-16-3-6.

Full text
Abstract:
Objective: to analyze short-term and long-term results of one-step surgery in resectable pancreatic head cancer (PHC), complicated by obstructive jaundice. Material and methods. The retrospective analysis of 123 consecutive cases of the surgical treatment of PHC has been performed. Group I (N = 33) consisted of patients with the total bilirubin level up to 100 µmol/l, group II (N = 31) - with the level of total bilirubin of 100-287 µmol/l who had undergone the one-step surgery. Group III (N = 59) included patients having undergone the surgical treatment with preoperative biliary drainage (PBD)
APA, Harvard, Vancouver, ISO, and other styles
6

Mikhailov, I. V., V. M. Bondarenko, V. A. Kudryashov, et al. "Dynamics of the Results of the Treatment of Resectable Pancreatic Head Cancer over a 30-Year Period." Health and Ecology Issues, no. 3 (September 28, 2019): 50–55. http://dx.doi.org/10.51523/2708-6011.2019-16-3-9.

Full text
Abstract:
Objective: to analyze the dynamics of the immediate and long-term results of the treatment of resectable pancreatic head cancer (PHC) for the period from 1989 to 2019. Material and methods. The retrospective analysis of 123 consecutive cases of the treatment of resectable PHC has been performed. During period I (from 1989 to 2000) 11 patients were operated, during period II (from 2001 to 2013) - 72, and period III (from 2014 to 2019) - 40 patients. The structure and frequency rate of postoperative complications, 90-day mortality and the overall survival rate (by the Kaplan-Meier method) have b
APA, Harvard, Vancouver, ISO, and other styles
7

Lim, Seungtaek, Hye Jin Choi, and Jinsil Seong. "Chemoradiation for locally advanced perihilar cholangiocarcinoma." Journal of Clinical Oncology 32, no. 3_suppl (2014): 372. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.372.

Full text
Abstract:
372 Background: Locally advanced perihilar cholangio-carcinoma (LA-PHC) is a rare malignancy with dismal prognosis, and chemoradiation (CRT) is used to palliate symptoms and extend survival. However, its role has not been established due to the rarity of these tumors. We intended to investigate the efficacy of chemo-concurrent radiotherapy (CRT) for patients with LA-PHC. Methods: This study included 52 patients who received CRT for LAPHC in a single institue. Patients received external beam radiotherapy with a median dose of 50.4Gy (range, 720-5400) with gemcitabine or 5-FU (or its analogues).
APA, Harvard, Vancouver, ISO, and other styles
8

Hashmi, Ammar, Zachary Kozick, Marcus Fluck, et al. "Neoadjuvant versus Adjuvant Chemotherapy for Resectable Pancreatic Adenocarcinoma: A National Cancer Database Analysis." American Surgeon 84, no. 9 (2018): 1439–45. http://dx.doi.org/10.1177/000313481808400946.

Full text
Abstract:
There is controversy regarding the role of neoadjuvant versus adjuvant chemotherapy for pancreatic cancer (PAC). Neoadjuvant therapy has been touted as a method to improve survival in PAC patients. This study's objective is to investigate predictors and potential benefits of neoadjuvant therapy in resectable PAC patients. The National Cancer Data Base was used to retrospectively analyze stage I and II surgically resected PAC patients receiving adjuvant or neoadjuvant therapy from 2004 to 2012. A total of 12,983 patients were identified. A significant increase in the rate of neoadjuvant therapy
APA, Harvard, Vancouver, ISO, and other styles
9

Tucker, Olga N., and Mohamed Rela. "Controversies in the Management of Borderline Resectable Proximal Pancreatic Adenocarcinoma with Vascular Involvement." HPB Surgery 2008 (March 11, 2008): 1–8. http://dx.doi.org/10.1155/2008/839503.

Full text
Abstract:
Synchronous major vessel resection during pancreaticoduodenectomy (PD) for borderline resectable pancreatic adenocarcinoma remains controversial. In the 1970s, regional pancreatectomy advocated by Fortner was associated with unacceptably high morbidity and mortality rates, with no impact on long-term survival. With the establishment of a multidisciplinary approach, improvements in preoperative staging techniques, surgical expertise, and perioperative care reduced mortality rates and improved 5-year-survival rates are now achieved following resection in high-volume centres. Perioperative morbid
APA, Harvard, Vancouver, ISO, and other styles
10

Narayan Singh, Basant, Rohith Kodali, Utpal Anand, et al. "Laparoscopic-assisted pancreaticoduodenectomy for periampullary carcinoma: An experience of 50 cases from a single tertiary care center." Turkish Journal of Surgery 40, no. 2 (2024): 126–35. http://dx.doi.org/10.47717/turkjsurg.2024.6419.

Full text
Abstract:
Objective: Laparoscopic-assisted pancreaticoduodenectomy (LAPD) is being performed in several centers worldwide. The proportion of minimally invasive pancreaticoduodenectomy for periampullary carcinoma (PAC) has recently increased, owing to its potential benefits. However, the safety and feasibility of LAPD have not yet been standardized. In this study, it was aimed to report our experience with LAPD in 50 patients. Material and Methods: Fifty patients with resectable PAC who underwent LAPD between June 2021 and August 2023 were retrospectively analyzed. Results: Mean age of the study group wa
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!